Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0O0YI
|
|||
| Drug Name |
PMID25656651-Compound-7
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
DECIPHERA PHARMACEUTICALS, LLC PETILLO, Peter, A. KAUFMAN, Michael, D. FLYNN, Daniel, L
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C30H28FN7O3
|
|||
| Canonical SMILES |
CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5
|
|||
| InChI |
1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)
|
|||
| InChIKey |
WVXNSAVVKYZVOE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1020172-07-9
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:62166
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.